Ventricular tachycardia associated with infusion of rituximab in mantle cell lymphoma [3]

American Journal of Hematology

Volumn 78, Issue 4, 2005, Pages 317-318

  Arai, Yukihiro ^a   Tadokoro, Jiro ^a   Mitani, Kinuko ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; CHLORPHENIRAMINE MALEATE; HYDROCORTISONE SODIUM SUCCINATE; RITUXIMAB;

AGED; BRADYCARDIA; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; FEVER; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HEPATOSPLENOMEGALY; HUMAN; LETTER; LUNG EMPHYSEMA; LYMPHADENOPATHY; MALE; MANTLE CELL LYMPHOMA; PRIORITY JOURNAL;

AGED; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; ELECTROCARDIOGRAPHY; HUMANS; INFUSIONS, INTRAVENOUS; LYMPHOMA, MANTLE-CELL; MALE; TACHYCARDIA, VENTRICULAR; TREATMENT OUTCOME;

EID: 16344377901     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.20303     Document Type: Letter

References (5)

1. Coiffier B, Lepage E, Briere J, et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large B-cell lymphoma. N Engl J Med 2002;346:235-242.
2. Lowndes S, Darby A, Mead G, Lister A. Stevens-Johnson syndrome after treatment with rituximab. Ann Oncol 2002;13:1948-1950.
3. Burton C, Kaczmarski R, Jan-Mohamed R. Interstitial pneumonitis related to rituximab therapy. N Engl J Med 2003;348:2690-2691.
4. Kunkel L, Wong A, Maneatis T, et al. Optimizing the use of rituximab for treatment of B-cell non-Hodgkin's lymphoma: a benefit-risk update. Semin Oncol 2000;27:53-61.
5. Foran JM, Rohatiner AZS, Cunningham D, et al. European phase II study of rituximab (chimeric anti-CD20 monoclonal antibody) for patients with newly diagnosed mantle-cell lymphoma and previously treated mantle-cell lymphoma, immunocytoma, and small B-cell lymphocytic lymphoma. J Clin Oncol 2000;18:317-324.